U.S. flag

An official website of the United States government

NM_000152.5(GAA):c.2483_2646+1del AND Glycogen storage disease, type II

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Mar 1, 1998
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000004246.7

Allele description [Variation Report for NM_000152.5(GAA):c.2483_2646+1del]

NM_000152.5(GAA):c.2483_2646+1del

Gene:
GAA:alpha glucosidase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17q25.3
Genomic location:
Preferred name:
NM_000152.5(GAA):c.2483_2646+1del
Other names:
Exon 18 del
HGVS:
  • NC_000017.11:g.80118194_80118358del
  • NG_009822.1:g.21639_21803del
  • NM_000152.5:c.2483_2646+1delMANE SELECT
  • NM_001079803.3:c.2483_2646+1del
  • NM_001079804.3:c.2483_2646+1del
  • LRG_673:g.21639_21803del
  • NC_000017.10:g.78091993_78092157del
Note:
NCBI reports the breakpoints for the deletion as defined by the GAA LSDB, GAA_00037
Nucleotide change:
EX18DEL
Links:
OMIM: 606800.0012; dbSNP: rs1555603048
NCBI 1000 Genomes Browser:
rs1555603048
Molecular consequence:
  • NM_000152.5:c.2483_2646+1del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001079803.3:c.2483_2646+1del - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001079804.3:c.2483_2646+1del - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Glycogen storage disease, type II (GSD2)
Synonyms:
ACID ALPHA-GLUCOSIDASE DEFICIENCY; GLYCOGENOSIS, GENERALIZED, CARDIAC FORM; GSD II; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009290; MedGen: C0017921; Orphanet: 365; OMIM: 232300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000024412OMIM
no assertion criteria provided
Pathogenic
(Mar 1, 1998)
germlineliterature only

PubMed (5)
[See all records that cite these PMIDs]

SCV000086727GeneReviews
no classification provided
not providedgermlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Deletion of exon 18 is a frequent mutation in glycogen storage disease type II.

Van der Kraan M, Kroos MA, Joosse M, Bijvoet AG, Verbeet MP, Kleijer WJ, Reuser AJ.

Biochem Biophys Res Commun. 1994 Sep 30;203(3):1535-41.

PubMed [citation]
PMID:
7945303

Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation.

Huie ML, Chen AS, Tsujino S, Shanske S, DiMauro S, Engel AG, Hirschhorn R.

Hum Mol Genet. 1994 Dec;3(12):2231-6.

PubMed [citation]
PMID:
7881425
See all PubMed Citations (6)

Details of each submission

From OMIM, SCV000024412.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (5)

Description

Van der Kraan et al. (1994) reported that deletion of exon 18 of the GAA gene is a frequent mutation in Pompe disease (GSD2; 232300). Huie et al. (1994) found this mutation in patients with both infantile and adult forms of this disease. Vorgerd et al. (1998) found homozygosity for the exon 18 deletion in 2 affected sibs and an unrelated patient with adult-type GSD II.

Boerkoel et al. (1995) found a deletion of exon 18 of the GAA gene in 3 unrelated compound heterozygous patients, 2 of whom were infants, and 1 an adult. The second mutation in each of these patients was different. The infants with Pompe disease were French Canadian and Dutch. The adult was a woman of German extraction who had first consulted her physician at age 39 years for progressive proximal muscle weakness and respiratory insufficiency. In retrospect, she could recall limitation in her activity as far back as early adulthood. In one of the infants, there was deletion of lys903 (606800.0007); in the other, there was a leu299-to-arg substitution (606800.0008). In the adult, the authors observed a T-to-G transversion at position -13 of intron 1 (606800.0006).

Although Kroos et al. (1995) found deletion of exon 18 in the infantile and adult forms of the disease, those homozygous for this mutation and heterozygous for this mutation in combination with deletion of 525T (606800.0014) had the infantile form of Pompe disease; however, patients with deletion of exon 18 or deletion of 525T in combination with transversion of T to G at position -13 (606800.0006) had the juvenile or the adult form, suggesting that the intronic mutation was a mild mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV000086727.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 18, 2023